16K prolactin induces NF-κB activation in pulmonary fibroblasts

Y. Macotela, C. Mendoza, A. M. Corbacho, G. Cosío, J. P. Eiserich, A. Zentella, G. Martínez de la Escalera, C. Clapp

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The amino-terminal 16 kDa fragment of prolactin (16K PRL) promotes the expression of the inducible isoform of nitric oxide synthase (iNOS) accompanied by the production of nitric oxide (NO) by rat pulmonary fibroblasts. The present study was designed to elucidate whether the mechanism by which 16K PRL promotes iNOS expression involves the activation of nuclear factor-kappa B (NF-κB), a key transcription factor for iNOS induction. 16K PRL stimulated DNA-binding activity of NF-κB in pulmonary fibroblasts as demonstrated by gel shift assays. Likewise, fluorescence immunocytochemistry showed that 16K PRL promotes nuclear translocation of the p65 subunit of NF-κB. Finally, treatment with 16K PRL induced the degradation of the NF-κB inhibitor κB-beta (IκB-β), and such degradation was prevented by blocking IκB-β phosphorylation. Altogether, these results show that 16K PRL activates NF-κB nuclear translocation via the phosphorylation and degradation of IκB-β. These findings are consistent with NF-κB being part of the signal transduction pathway activated by 16K PRL to induce iNOS expression.

Original languageEnglish (US)
JournalJournal of Endocrinology
Volume175
Issue number3
StatePublished - Dec 1 2002

Fingerprint

NF-kappa B
Prolactin
Fibroblasts
Lung
Protein Isoforms
Nitric Oxide Synthase
Phosphorylation
Nitric Oxide Synthase Type II
Signal Transduction
Nitric Oxide
Transcription Factors
Fluorescence
Gels
Immunohistochemistry
DNA

ASJC Scopus subject areas

  • Endocrinology

Cite this

Macotela, Y., Mendoza, C., Corbacho, A. M., Cosío, G., Eiserich, J. P., Zentella, A., ... Clapp, C. (2002). 16K prolactin induces NF-κB activation in pulmonary fibroblasts. Journal of Endocrinology, 175(3).

16K prolactin induces NF-κB activation in pulmonary fibroblasts. / Macotela, Y.; Mendoza, C.; Corbacho, A. M.; Cosío, G.; Eiserich, J. P.; Zentella, A.; Martínez de la Escalera, G.; Clapp, C.

In: Journal of Endocrinology, Vol. 175, No. 3, 01.12.2002.

Research output: Contribution to journalArticle

Macotela, Y, Mendoza, C, Corbacho, AM, Cosío, G, Eiserich, JP, Zentella, A, Martínez de la Escalera, G & Clapp, C 2002, '16K prolactin induces NF-κB activation in pulmonary fibroblasts', Journal of Endocrinology, vol. 175, no. 3.
Macotela Y, Mendoza C, Corbacho AM, Cosío G, Eiserich JP, Zentella A et al. 16K prolactin induces NF-κB activation in pulmonary fibroblasts. Journal of Endocrinology. 2002 Dec 1;175(3).
Macotela, Y. ; Mendoza, C. ; Corbacho, A. M. ; Cosío, G. ; Eiserich, J. P. ; Zentella, A. ; Martínez de la Escalera, G. ; Clapp, C. / 16K prolactin induces NF-κB activation in pulmonary fibroblasts. In: Journal of Endocrinology. 2002 ; Vol. 175, No. 3.
@article{50550d1fc0bc4647b3e71904cf681dbc,
title = "16K prolactin induces NF-κB activation in pulmonary fibroblasts",
abstract = "The amino-terminal 16 kDa fragment of prolactin (16K PRL) promotes the expression of the inducible isoform of nitric oxide synthase (iNOS) accompanied by the production of nitric oxide (NO) by rat pulmonary fibroblasts. The present study was designed to elucidate whether the mechanism by which 16K PRL promotes iNOS expression involves the activation of nuclear factor-kappa B (NF-κB), a key transcription factor for iNOS induction. 16K PRL stimulated DNA-binding activity of NF-κB in pulmonary fibroblasts as demonstrated by gel shift assays. Likewise, fluorescence immunocytochemistry showed that 16K PRL promotes nuclear translocation of the p65 subunit of NF-κB. Finally, treatment with 16K PRL induced the degradation of the NF-κB inhibitor κB-beta (IκB-β), and such degradation was prevented by blocking IκB-β phosphorylation. Altogether, these results show that 16K PRL activates NF-κB nuclear translocation via the phosphorylation and degradation of IκB-β. These findings are consistent with NF-κB being part of the signal transduction pathway activated by 16K PRL to induce iNOS expression.",
author = "Y. Macotela and C. Mendoza and Corbacho, {A. M.} and G. Cos{\'i}o and Eiserich, {J. P.} and A. Zentella and {Mart{\'i}nez de la Escalera}, G. and C. Clapp",
year = "2002",
month = "12",
day = "1",
language = "English (US)",
volume = "175",
journal = "Journal of Endocrinology",
issn = "0022-0795",
publisher = "Society for Endocrinology",
number = "3",

}

TY - JOUR

T1 - 16K prolactin induces NF-κB activation in pulmonary fibroblasts

AU - Macotela, Y.

AU - Mendoza, C.

AU - Corbacho, A. M.

AU - Cosío, G.

AU - Eiserich, J. P.

AU - Zentella, A.

AU - Martínez de la Escalera, G.

AU - Clapp, C.

PY - 2002/12/1

Y1 - 2002/12/1

N2 - The amino-terminal 16 kDa fragment of prolactin (16K PRL) promotes the expression of the inducible isoform of nitric oxide synthase (iNOS) accompanied by the production of nitric oxide (NO) by rat pulmonary fibroblasts. The present study was designed to elucidate whether the mechanism by which 16K PRL promotes iNOS expression involves the activation of nuclear factor-kappa B (NF-κB), a key transcription factor for iNOS induction. 16K PRL stimulated DNA-binding activity of NF-κB in pulmonary fibroblasts as demonstrated by gel shift assays. Likewise, fluorescence immunocytochemistry showed that 16K PRL promotes nuclear translocation of the p65 subunit of NF-κB. Finally, treatment with 16K PRL induced the degradation of the NF-κB inhibitor κB-beta (IκB-β), and such degradation was prevented by blocking IκB-β phosphorylation. Altogether, these results show that 16K PRL activates NF-κB nuclear translocation via the phosphorylation and degradation of IκB-β. These findings are consistent with NF-κB being part of the signal transduction pathway activated by 16K PRL to induce iNOS expression.

AB - The amino-terminal 16 kDa fragment of prolactin (16K PRL) promotes the expression of the inducible isoform of nitric oxide synthase (iNOS) accompanied by the production of nitric oxide (NO) by rat pulmonary fibroblasts. The present study was designed to elucidate whether the mechanism by which 16K PRL promotes iNOS expression involves the activation of nuclear factor-kappa B (NF-κB), a key transcription factor for iNOS induction. 16K PRL stimulated DNA-binding activity of NF-κB in pulmonary fibroblasts as demonstrated by gel shift assays. Likewise, fluorescence immunocytochemistry showed that 16K PRL promotes nuclear translocation of the p65 subunit of NF-κB. Finally, treatment with 16K PRL induced the degradation of the NF-κB inhibitor κB-beta (IκB-β), and such degradation was prevented by blocking IκB-β phosphorylation. Altogether, these results show that 16K PRL activates NF-κB nuclear translocation via the phosphorylation and degradation of IκB-β. These findings are consistent with NF-κB being part of the signal transduction pathway activated by 16K PRL to induce iNOS expression.

UR - http://www.scopus.com/inward/record.url?scp=0036923014&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036923014&partnerID=8YFLogxK

M3 - Article

C2 - 12475392

AN - SCOPUS:0036923014

VL - 175

JO - Journal of Endocrinology

JF - Journal of Endocrinology

SN - 0022-0795

IS - 3

ER -